Abstract
A 64-kDa dimeric lectin was purified from Phaseolus vulgaris cv. Japanese mottled beans. The purification protocol involved ion exchange chromatography with Q-Sepharose and SP-Sepharose and size exclusion chromatography on Superdex 75. The lectin was adsorbed on both Q-Sepharose and SP-Sepharose columns. Finally, the lectin gave a sharp absorbance peak which corresponded to 64 kDa based on results of size exclusion chromatography. Sodium dodecyl sulphate- polyacrylamide gel electrophoresis displayed a single band at around 32 kDa, indicating that the protein was dimeric. The hemagglutination inhibition assay indicated that the lectin showed specificity toward galactose. The lectin preserved hemagglutinating activity below 70 °C and at a pH range 3 – 12. The lectin was able to inhibit proliferation of MCF-7 cells and Hep G2 cells and possessed antifungal activity toward Mycosphaeralla arachidicola with an IC50 value of 3.9 µM. The activity of HIV-1 reverse transcriptase was reduced by 61.9 % in the presence of the lectin at 6.25 µM concentration.
Keywords: Antitumor, Japanese mottled beans, lectin, purification.
Protein & Peptide Letters
Title:Isolation and Characterization of a Lectin from Japanese Mottled Beans
Volume: 21 Issue: 7
Author(s): Yuan Zhao, Ameer Maqsood Ahmad, Randy Chi Fai Cheung and Tzi Bun Ng
Affiliation:
Keywords: Antitumor, Japanese mottled beans, lectin, purification.
Abstract: A 64-kDa dimeric lectin was purified from Phaseolus vulgaris cv. Japanese mottled beans. The purification protocol involved ion exchange chromatography with Q-Sepharose and SP-Sepharose and size exclusion chromatography on Superdex 75. The lectin was adsorbed on both Q-Sepharose and SP-Sepharose columns. Finally, the lectin gave a sharp absorbance peak which corresponded to 64 kDa based on results of size exclusion chromatography. Sodium dodecyl sulphate- polyacrylamide gel electrophoresis displayed a single band at around 32 kDa, indicating that the protein was dimeric. The hemagglutination inhibition assay indicated that the lectin showed specificity toward galactose. The lectin preserved hemagglutinating activity below 70 °C and at a pH range 3 – 12. The lectin was able to inhibit proliferation of MCF-7 cells and Hep G2 cells and possessed antifungal activity toward Mycosphaeralla arachidicola with an IC50 value of 3.9 µM. The activity of HIV-1 reverse transcriptase was reduced by 61.9 % in the presence of the lectin at 6.25 µM concentration.
Export Options
About this article
Cite this article as:
Zhao Yuan, Ahmad Maqsood Ameer, Cheung Chi Fai Randy and Ng Bun Tzi, Isolation and Characterization of a Lectin from Japanese Mottled Beans, Protein & Peptide Letters 2014; 21 (7) . https://dx.doi.org/10.2174/0929866521666140320100308
DOI https://dx.doi.org/10.2174/0929866521666140320100308 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets The Use of Immunotherapy to Treat Metastatic Breast Cancer
Current Medicinal Chemistry Ruthenium Antimetastatic Agents
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Protein Targets in the Treatment of Cancers (Guest Editor: Sabbir Ahmed)]
Anti-Cancer Agents in Medicinal Chemistry Recent Advances of Metal Binding Protein Lactoferrin as an Anti- Microbial Agent
Current Bioactive Compounds Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Traditional Medicine-based Cardiovascular Drug Research
Current Drug Metabolism Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression
Current Drug Targets Statins and Ischaemia Reperfusion Injury: A Molecular Biological Review
Current Vascular Pharmacology Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
Current Pharmaceutical Design Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Recent Patents on Drug Delivery & Formulation Impact of a Psycho-Educational Team in early Breast Cancer Patients’ Coping Strategies: The Venere Project
Reviews on Recent Clinical Trials Inventions Designed to Enhance Drug Delivery Across Epithelial and Endothelial Cells Through the Paracellular Pathway
Recent Patents on Drug Delivery & Formulation Inflammation as a Therapeutic Target in Acute Ischemic Stroke Treatment
Current Topics in Medicinal Chemistry Chemotherapeutic Properties of n-3 Polyunsaturated Fatty Acids - Old Concepts and New Insights
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent
Current Cancer Drug Targets New Insights in Drug-Induced Mitochondrial Toxicity
Current Pharmaceutical Design Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
Clinical Cancer Drugs New Entrants into Clinical Trials for Targeted Therapy of Breast Cancer: An Insight
Anti-Cancer Agents in Medicinal Chemistry Vascular Homing Peptides with Cell-Penetrating Properties
Current Pharmaceutical Design